Name: Pediatric Cancers (en Inglés)
Price: 486849.00 COP
Availability: InStock
Author: Agarwal, Saurabh ; Yang, Jianhua
ISBN: 9783036590240

Formato

Libro Físico

Editorial

Mdpi AG

Autor

Agarwal, Saurabh ; Yang, Jianhua

Idioma

Inglés

N° páginas

456

Encuadernación

Tapa Dura

Dimensiones

24.4 x 17.0 x 3.5 cm

Peso

1.17 kg.

ISBN13

9783036590240

Categorías

Biología

Pediatric Cancers (en Inglés)

Agarwal, Saurabh ; Yang, Jianhua (Autor) · Mdpi AG · Tapa Dura

Libro Nuevo

$ 486.849

$ 811.415

Ahorras: $ 324.566

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 17 de Julio y el Viernes 26 de Julio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Pediatric Cancers (en Inglés)"

Childhood cancer or pediatric cancer is one of the leading causes of death among children. Treatment strategies for pediatric cancers include chemotherapy, surgery, radiation, and stem cell transplantation. These therapeutic regimens are well known to develop highly toxic and long-lasting side-effects including secondary cancers in the future lifespan of pediatric patients. Despite these intensive therapeutic regimens, cancer may still relapse as refractory and metastatic cancer. Therefore, further understanding the causes of different pediatric cancers, mechanisms of drug-resistance, and causes of relapse and metastasis is required for developing and advancing less toxic and more effective therapeutic strategies for pediatric cancers. Recent advancements in immunotherapies and targeted therapeutic approaches using pharmacological inhibitors are one step in this direction.In this Special Issue of Cancers, authors contributed original research and review articles focusing on different aspects of pediatric cancer development, causes, maintenance, and therapeutic strategies. The collected articles in this Special Issue will further enhance our knowledge and understanding of pediatric cancers and drive the development of novel therapeutic strategies.